Korro Bio (NASDAQ: KRRO) investors back directors, pay and auditor

Filing Impact

(Moderate)

Filing Sentiment

(Neutral)

Form Type

8-K

Rhea-AI Filing Summary

Korro Bio, Inc. reported the results of its 2026 annual stockholder meeting held on June 10, 2026. Stockholders elected Nessan Bermingham and Rachel Meyers as Class I directors for three-year terms ending at the 2029 annual meeting.

Both directors received several million votes in favor, with additional votes withheld and broker non-votes recorded. Stockholders also approved, in a non-binding advisory vote, the compensation of Korro’s named executive officers by a wide margin.

In addition, stockholders ratified the selection of Ernst & Young LLP as Korro’s independent registered public accounting firm for the fiscal year ending December 31, 2026. These items collectively confirm continued support for the company’s board, executive pay program, and auditor.

8-K Event Classification

Item 5.07 — Submission of Matters to a Vote of Security Holders

1 item

Item 5.07 Submission of Matters to a Vote of Security Holders Governance

Results of a shareholder vote on proposals at an annual or special meeting.

Key Figures

Election votes - Nessan Bermingham: 7,468,003 for; 1,576,660 withheld; 1,875,955 broker non-votes Election votes - Rachel Meyers: 7,368,284 for; 1,676,379 withheld; 1,875,955 broker non-votes Say-on-pay advisory vote: 9,009,739 for; 27,988 against; 6,936 abstain; 1,875,955 broker non-votes +3 more

6 metrics

Election votes - Nessan Bermingham 7,468,003 for; 1,576,660 withheld; 1,875,955 broker non-votes Class I director election at 2026 annual meeting

Election votes - Rachel Meyers 7,368,284 for; 1,676,379 withheld; 1,875,955 broker non-votes Class I director election at 2026 annual meeting

Say-on-pay advisory vote 9,009,739 for; 27,988 against; 6,936 abstain; 1,875,955 broker non-votes Compensation of named executive officers

Auditor ratification vote 10,917,621 for; 2,738 against; 259 abstain; 0 broker non-votes Ratification of Ernst & Young LLP for FY 2026

Annual meeting date June 10, 2026 2026 annual meeting of stockholders

Fiscal year end for auditor engagement December 31, 2026 Ernst & Young LLP engagement period

Key Terms

Emerging growth company, non-binding, advisory vote, independent registered public accounting firm, Broker Non-Votes, +1 more

5 terms

Emerging growth company regulatory

"Emerging growth company Item 5.07. Submission of Matters to a Vote"

An emerging growth company is a recently public or smaller public firm that qualifies for temporary, lighter regulatory and disclosure rules to reduce the cost and effort of being public. For investors, it means the company may provide less historical financial detail and face fewer reporting requirements than larger firms, so it can grow more quickly but also carries higher uncertainty—like buying a promising early-stage product with fewer user reviews.

non-binding, advisory vote regulatory

"stockholders approved, in a non-binding, advisory vote, the compensation"

independent registered public accounting firm regulatory

"ratified the selection of Ernst & Young LLP as its independent registered public accounting firm"

An independent registered public accounting firm is an outside accounting company officially registered with the government regulator to examine and report on a public company's financial records and controls. Investors treat its reports like an impartial inspector’s certificate — they add credibility to financial statements, help spot errors or misleading claims, and reduce the risk that shareholders are relying on unchecked or biased numbers.

Broker Non-Votes financial

"Votes For | | Votes Withheld | | Broker Non-Votes"

Broker non-votes occur when a brokerage firm is unable to vote on a shareholder’s behalf during a company election or decision because the shareholder has not given specific voting instructions, and the broker is not allowed or chooses not to vote on certain matters. They are important because they can affect the outcome of votes, especially when the results are close, by effectively reducing the total number of votes cast.

Class I directors financial

"elected each of Nessan Bermingham and Rachel Meyers as Class I directors"

Class I directors are the subset of a company’s board whose terms expire at a specific annual meeting under a staggered election system that divides directors into multiple groups with different re-election years. For investors this matters because staggered classes slow how quickly shareholders can replace the board, affecting takeover risk, governance change and the pace of corporate decisions — like rotating only part of a team instead of swapping everyone at once.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Understanding 8-K Material Events →

06/11/2026 - 04:42 PM

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): June 10, 2026

Korro Bio, Inc.

(Exact name of registrant as specified in its charter)


Delaware	001-39062	47-2324450
(State or other jurisdiction of incorporation)	(Commission File Number)	(IRS Employer Identification No.)
60 First Street, 2nd floor, Suite 250 Cambridge, MA		02141
(Address of principal executive offices)		(Zip Code)

Registrant’s telephone number, including area code: (617) 468-1999

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:


☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:


Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common stock, par value $0.001 per share	KRRO	The Nasdaq Capital Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 5.07. Submission of Matters to a Vote of Security Holders.

The following is a summary of the matters voted on at the 2026 annual meeting of stockholders of Korro Bio, Inc., or Korro, held on June 10, 2026, or the Annual Meeting.

Korro’s stockholders elected each of Nessan Bermingham and Rachel Meyers as Class I directors, each for a three-year term ending at the annual meeting of stockholders to be held in 2029 and each until his or her respective successor has been duly elected and qualified or until his or her earlier death, resignation or removal. The results of the stockholders’ vote with respect to the election of the two Class I directors are as follows:


Name	Votes For	Votes Withheld	Broker Non-Votes
Nessan Bermingham	7,468,003	1,576,660	1,875,955
Rachel Meyers	7,368,284	1,676,379	1,875,955

Korro’s stockholders approved, in a non-binding, advisory vote, the compensation of Korro’s named executive officers. The results of the stockholders’ advisory vote with respect to the compensation of Korro’s named executive officers are as follows:


Votes For	Votes Against	Abstain	Broker Non-Votes
9,009,739	27,988	6,936	1,875,955

Korro’s stockholders ratified the selection of Ernst & Young LLP as its independent registered public accounting firm for the fiscal year ending December 31, 2026. The results of the stockholders’ vote with respect to such ratification are as follows:


Votes For	Votes Against	Abstain	Broker Non-Votes
10,917,621	2,738	259	0

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


	KORRO BIO, INC.

Date: June 11, 2026	By:	/s/ Ram Aiyar

		Name: Ram Aiyar
		Title: President and Chief Executive Officer and Interim Chief Financial Officer

Source: View Original Filing on SEC EDGAR

FAQ

What did Korro Bio (KRRO) stockholders decide at the 2026 annual meeting?

Korro Bio stockholders elected two Class I directors, approved executive compensation in a non-binding advisory vote, and ratified Ernst & Young LLP as independent auditor for 2026, signaling broad support for the company’s governance and oversight choices.

Who was elected to Korro Bio (KRRO)’s board at the 2026 annual meeting?

Stockholders elected Nessan Bermingham and Rachel Meyers as Class I directors for three-year terms ending at the 2029 annual meeting. They will serve until successors are elected and qualified or earlier death, resignation, or removal under the company’s governance framework.

How did Korro Bio (KRRO) shareholders vote on executive compensation?

Shareholders approved the compensation of Korro Bio’s named executive officers in a non-binding advisory vote. There were 9,009,739 votes for, 27,988 against, 6,936 abstentions, and 1,875,955 broker non-votes, indicating strong overall support for the pay program.

Which audit firm did Korro Bio (KRRO) stockholders ratify for fiscal 2026?

Stockholders ratified Ernst & Young LLP as Korro Bio’s independent registered public accounting firm for the fiscal year ending December 31, 2026. The vote totaled 10,917,621 for, 2,738 against, and 259 abstentions, with no broker non-votes recorded on this item.

What is a broker non-vote in Korro Bio (KRRO)’s 2026 meeting results?

A broker non-vote occurs when a broker does not have authority to vote uninstructed shares on a proposal. In Korro Bio’s meeting, broker non-votes appeared on director elections and the compensation advisory vote, but not on the auditor ratification item, where brokers could vote.

Filing Exhibits & Attachments

1 document